A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis

NCT02161406 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Cutaneous Systemic Sclerosis

Interventions

DRUG: Abatacept
DRUG: Placebo

Sponsor

Dinesh Khanna, MD, MS

Collaborators

[object Object]
[object Object]